ResMed Names Gallahue as New CEO

SAN DIEGO–Sleep product manufacturer ResMed announced last week
that its board of directors has unanimously approved a succession
plan for executive management of the company.

Effective Jan. 1, Kieran T. Gallahue will be promoted to CEO and
will join the board of directors. Gallahue will succeed Dr. Peter
C. Farrell, the company’s founder, who will continue as executive
chairman of the board until June 30, 2008, when he will become
non-executive chairman.

“Since joining ResMed in 2003, Kieran has demonstrated strong
leadership qualities,” said Farrell. “He has been instrumental in
improving our operational execution, targeting our research and
development efforts, focusing our commercial teams to better serve
patients and customers, while strengthening the depth of our
management.” Gallahue is “the right person to succeed me,” Farrell
added.

“Since founding the company in 1989, I have been passionate
about the need to increase awareness of sleep-disordered breathing
among both the public and the medical community, as well as the
need to increase understanding of the deleterious consequences of
the disease if left untreated,” Farrell continued. “As chairman, I
intend to remain significantly engaged in the company’s mission and
strategy.”

“I am excited about the opportunities ahead of us–a vast
untapped market, market-leading technology and a world class team
of employees,” Gallahue said.

Gallahue joined ResMed in January 2003 as president and COO of
the Americas, and in September 2004 was named president and
COO-ResMed Global. Before joining the company, Gallahue was
president of Nanogen, a San Diego-based DNA research and medical
diagnostics company. Earlier in his career, he worked for
Instrumentation Laboratory, Procter & Gamble and General
Electric.